Skip to content

Author

S. Elimeleh

We have 5 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Sex-specific impact of chronic kidney disease on mortality and dialysis in heart failure with metabolic syndrome

Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder defined by the overlapping burden of heart failure (HF), chronic kidney disease (CKD), diabetes, and obesity. Although sex differences in cardiovascular disease are increasingly recognized, sex-specific patterns of mortality and renal progressi...

D. Hochstein, R. Loutati, V. Copeland et al. · 0 citations
Open access Oct 2026

Improving outcomes in HFpEF with advanced CKD: temporal trends from the SHEBAHEART Registry

Patients with advanced chronic kidney disease (CKD) and heart failure (HF) are systematically underrepresented in clinical trials despite comprising a substantial proportion of real-world HF populations [1]. Whether contemporary care has translated into improved outcomes in this high-risk group particularly among...

D. Hochstein, D. Sternik, V. Copeland et al. · 0 citations
Open access Sep 2026

Random Urinary Calcium/Creatinine Ratio as a Predictor of Dehydration in Hypercalcemic and Normocalcemic Patients

Background/Objectives: Dehydration is an under-recognized cause of hypercalcemia, and no validated bedside marker exists to distinguish it from other etiologies. We evaluated the urinary calcium-to-creatinine ratio (uCa/Cr) and the fractional excretion of calcium (FeCa) as predictors of dehydration across a spectrum of...

R. Tal-Ben Ishay, Yossi Asaf, M. Canetti et al. · 0 citations
Sep 2026

Calcium Channel Blockers are Safe and Beneficial in Patients with Heart Failure and Advanced Chronic Kidney Disease.

In patients with heart failure and advanced chronic kidney disease, CCBs use was associated with improved survival, supporting their potential role as a safe adjunctive therapy for blood pressure control in this high-risk population.

V. Copeland, A. Milwidsky, S. Elimeleh et al. · 0 citations
Aug 2026

Frailty Attenuates the Prognostic Value of Multimorbidity in Heart Failure - Insights From the Largest Tertiary Center in the Middle East.

Frailty fundamentally attenuates risk in HF, while multimorbidity stratifies prognosis only when physiological reserve is preserved, while multimorbidity stratifies prognosis only when physiological reserve is preserved.

V. Copeland, Boris Fishman, S. Elimeleh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.